The personal genomics startup game

Drew Yates at ThinkGene has a delightfully cynical take on the personal genomics industry:

I know 23andMe's game, it's the "break the mean with variance" game,
and it's the same Silicon Valley game that's been played by internet
media companies for the last decade. How to play: a network of superior
talent and funding backs a group of startups that executes something
outrageous and otherwise unobtainable by contractual or legal
permission (like YouTube, Napster, Google itself... have we forgotten the
shear audacity of copying all the information in the world without
permission?) Then, that startup pushes to spread that new idea as far
into the public as possible before lumbering regulatory agencies and
competitors can react. When the opposition (like RIAA, the State of New
York, etc) finally mounts a counter attack, it now must compromise
between the unsustainable but irretractable audacity of the startup and
the previous status quo. The resulting compromise between these two
extremes settles far beyond what could have been arranged in advance.

I'm incredibly naive when it comes to the biotech business world, so I can't testify to the accuracy of Drew's depiction - but any comments from industry insiders would be welcomed.

Subscribe to Genetic Future.

More like this

Personalised medicine pioneers Helix Health have announced their intention to seize control of the assets of personal genomics company 23andMe. Helix Health founder Steve Murphy (left) laid out his takeover plans during a press conference this morning. "It's time to seize the moral high ground…
Yesterday I discussed the decision of personal genomics company 23andMe to slash its price for a genome scan by 60%, to under $400. In the comments to that post, industry observer David Hamilton pointed me to an article he's written for BNET on the implications of 23andMe's price plunge, which (…
Over at Gene Expression, Razib suggests that trouble lies ahead for personal genomics company 23andMe. Although I'm generally a bit of a cheerleader for the Mountain View-based startup, I must admit the signs over the past year or so haven't been good: two rounds of lay-offs, the departure of co-…
23andMe is one of three companies currently providing chip-based personal genomics assays, which provide information about up to a million sites of common variation throughout the human genome. These companies provide insight into a limited but informative slice of your genetic diversity, as I…

Why stop at genetics? Your ancestry (ancestry.com) can tell you quite a bit as well.

Maybe Drew needs to look into government protection from them (and many others like them).

One should be dismissive of anyone afraid of the "public" having information without government oversight, IMHO.

@marc: If you'd like to learn more about government programs, your local city library offers personalized literacy coaching at no cost for qualified community members.

@Daniel: I'm incredibly naive, too, but that seems to describe how the startup game is played ---intentionally or not.

@Andrew Yates

"Reasonable people adapt themselves to the world. Unreasonable people attempt to adapt the world to themselves. All progress, therefore, depends on unreasonable people." -- George Bernard Shaw